EUVIMEDEUVIMED entdecken
Crossref

Catalpol ameliorates intervertebral disc degeneration by suppressing NP cell Pyroptosis via the NF-ĸB pathway

Chenhua Wang, Weidong Liang, Fengyun Yang, Peng Zhu, Yubo Cui, Yizhong Lu, Wenlong Yang, Weifeng Ji, Guisong Yu

International Immunopharmacology · 2026-10 · 186 · 117118

DOI: 10.1016/j.intimp.2026.117118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Chenhua Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine School of Clinical Medicine, Jiangxi, Nanchang 330004, China. Hauptthemen laut MEDLINE: Iridoid Glucosides, Pyroptosis, Intervertebral Disc Degeneration, Nucleus Pulposus. Die Arbeit nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intervertebral disc degeneration (IDD) is a prevalent degenerative disorder and a leading cause of low back pain. Catalpol (CAT) possesses recognized anti-inflammatory and antioxidant properties and shows therapeutic potential for various inflammatory diseases; however, its role in IDD remains unclear. This study aimed to investigate the protective effects of CAT against IDD and to elucidate its underlying mechanism. The study employed both in vitro and in vivo experimental models. The effects of CAT on IDD progression were assessed, with a focus on nucleus pulposus (NP) cell pyroptosis. Mechanistic investigations were conducted to examine the involvement of the NF-κB/NLRP3-mediated pyroptotic pathway, including the nuclear translocation of phosphorylated P65 (p-P65). The dependence of CAT's action on this pathway was further verified through P65 overexpression experiments. CAT was demonstrated to alleviate IDD in experimental models. It exerted its protective effect by inhibiting pyroptosis in NP cells. Mechanistically, CAT blocked the nuclear translocation of p-P65, thereby suppressing the NF-κB/NLRP3-mediated pyroptotic pathway. The reversal of CAT's protective effects upon P65 overexpression confirmed that its action is dependent on this pathway. This study reveals that CAT alleviates IDD by directly targeting P65 to inhibit NP cell pyroptosis via the NF-κB/NLRP3 pathway. These findings identify CAT as a novel therapeutic candidate and provide a mechanistic insight for the treatment of intervertebral disc degeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iridoid GlucosidesPyroptosisIntervertebral Disc DegenerationNucleus PulposusAnti-Inflammatory AgentsAnimalsNLR Family, Pyrin Domain-Containing 3 ProteinSignal TransductionNF-kappa BMaleTranscription Factor RelARats, Sprague-DawleyRatsCells, CulturedDisease Models, AnimalHumans

Stichwörter der Autor:innen

CatalpolIntervertebral disc degenerationNLRP3Nucleus pulposus cellsP65Pyroptosis

Substanzen

Iridoid GlucosidescatalpolNLR Family, Pyrin Domain-Containing 3 ProteinNF-kappa BTranscription Factor RelAAnti-Inflammatory AgentsNlrp3 protein, rat

Autor:innen und Institutionen

  • Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine School of Clinical Medicine, Jiangxi, Nanchang 330004, China.
  • Affiliated Hospital of Jiangxi University of traditional Chinese Medicine, Jiangxi, Nanchang 330006, China.
  • Gao'an Hospital of Traditional Chinese Medicine, Gao'an, Jiangxi, China.
  • Department of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China.
  • Department of Orthopaedics and Traumatology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China. Electronic address: 2003…
  • Department of Traumatology and Orthopedics, Lishui People's Hospital, Lishui, Zhejiang 323000, China; Jiangxi University of Chinese Medicine, Jiangxi University of Chinese Medicine School of Clinical Medicine, Jiangxi,…

Zitieren

APA

Wang, C., Liang, W., Yang, F., Zhu, P., Cui, Y., Lu, Y., Yang, W., Ji, W., & Yu, G. (2026). Catalpol ameliorates intervertebral disc degeneration by suppressing NP cell Pyroptosis via the NF-ĸB pathway. International Immunopharmacology, 186, 117118. https://doi.org/10.1016/j.intimp.2026.117118

Vancouver

Wang C, Liang W, Yang F, Zhu P, Cui Y, Lu Y, et al. Catalpol ameliorates intervertebral disc degeneration by suppressing NP cell Pyroptosis via the NF-ĸB pathway. International Immunopharmacology. 2026;186:117118. doi:10.1016/j.intimp.2026.117118

BibTeX
@article{Wang2026,
  author = {Wang, Chenhua and Liang, Weidong and Yang, Fengyun and Zhu, Peng and Cui, Yubo and Lu, Yizhong and Yang, Wenlong and Ji, Weifeng and Yu, Guisong},
  title = {Catalpol ameliorates intervertebral disc degeneration by suppressing NP cell Pyroptosis via the NF-ĸB pathway},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {186},
  pages = {117118},
  doi = {10.1016/j.intimp.2026.117118}
}
Kostenlos starten →